Another study found that NR3C1 enhancement up-regulated FTO protein levels in β-cells and that the specific FTO inhibitor Dac51 effectively rescued NR3C1-induced β-cell failure, hyperglycemia, and glucose intolerance in diabetes models (31). This evidence concerns the gene FTO and Hyperglycemia.